Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 194

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 194
---
                  | - |     |            | 14,284 |     |                 |  914 |   |     |             | -       |   |     |        | 15,221 |   |
| Stock based compensation                       |     |               |          - |     |               |  - |     |                  | - |     |                  | - |     |            |  1,433 |     |                 | (144 | ) |     |             | -       |   |     |        |  1,289 |   |
| Balance at December 31, 2024                   |     |               | 60,729,100 |     |               | 61 |     |                  | - |     |                  | - |     |            | 30,388 |     |                 |  770 |   |     |             | (11,513 | ) |     |        | 19,706 |   |

<div align='center'>The accompanying notes are an integral part of
these financial statements.

F-6</div>

REVIUM RX.

CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

|                                                                             |     | Successor      
 For the period 
 commencing     
 July 24        
 through        
 December 31,   
 2024           |        |   |     | Predecessor    
 For the period 
 commencing     
 January 1      
 through        
 July 23,       
 2024           |        |   |     | For the year ended 
 December 31,       
 2023               |        |   |
|:----------------------------------------------------------------------------|:----|:---------------|-------:|:--|:----|:---------------|-------:|:--|:----|:-------------------|-------:|:--|
| CASH FLOWS FROM OPERATING ACTIVITIES:                                       |     |                |        |   |     |                |        |   |     |                    |        |   |
| Net loss                                                                    |     |                | (2,084 | ) |     |                | (1,421 | ) |     |                    |   (987 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |     |                |        |   |     |                |        |   |     |                    |        |   |
| Finance income                                                              |     |                |     (4 | ) |     |                |